about
Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendationsGaps between Global Guidelines and Local Practices in CKD-MBDBilateral acute renal cortical necrosis in SLE-associated antiphospholipid syndrome.Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules.Bilateral renal cortical necrosis following binge drinking.The role of proximal nephron in cyclophosphamide-induced water retention: preliminary dataRegulation of the abundance of renal sodium transporters and channels by vasopressin.Thiazide-induced hyponatremiaLong-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients.Clinicopathologic Features of IgA-Dominant Postinfectious GlomerulonephritisCicletanine-induced hyponatremia and hypokalemia in kidney transplant patientsAssociation between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.The rate of decline of glomerular filtration rate is a predictor of long-term graft outcome after kidney transplantation.Postdialysis serum sodium changes and systolic blood pressure in patients undergoing online hemodiafiltration and high-flux hemodialysis.Prognostic Significance of 1-Year Serum Albumin Levels Within the Normal Range After Kidney Transplantation.Is tolvaptan indicated for refractory oedema in nephrotic syndrome?Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.Fractional excretion of uric acid as a predictor for saline responsiveness in long-term kidney transplant patients.Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel.Treating lithium-induced nephrogenic diabetes insipidus with a COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2.Roles of claudin-2, ZO-1 and occludin in leaky HK-2 cells.Evaluation of Urinary Indices for Albuminuria and Proteinuria in Patients with Chronic Kidney Disease.Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.Hyponatraemia induced by low-dose intravenous pulse cyclophosphamide.Corrigendum to "Hwang KS, Kim GH: Thiazide-induced Hyponatremia. Electrolyte Blood Press 8:51-57, 2010".Chronic furosemide or hydrochlorothiazide administration increases H+-ATPase B1 subunit abundance in rat kidneyAnalysis of Allograft Biopsy Specimens in Renal Transplants With Proteinuria: Is Proteinuria a Culprit of Graft Loss?Tight junction protein expression from peritoneal dialysis EffluentPharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney DiseaseHepcidin as a Biomarker of Cardiorenal SyndromeThe fate of manuscripts rejected from Kidney Research and Clinical Practice
P50
Q26781361-411BB2B6-0850-4122-8F96-8C622B74303CQ27022356-36598D02-480C-4CA8-AC7B-21A7183E8F7FQ33395012-B1E7DAE4-817D-4041-99B6-D7F5F6A35CADQ33691644-7BB27133-1E0D-453F-9925-0CB3BA012495Q34030058-9B5858DA-581B-48B7-8CD0-D1718DB5585DQ34048114-0C9CF338-C1C9-4A94-B701-A002729D1F4AQ34382666-F80141CF-289F-4386-BC6E-20307530C293Q34584727-ED078E5C-6D47-4A78-9A8B-9FBBA7869E47Q36318268-E0751DF3-44BF-4480-A264-AD2893FF6615Q36343581-3B8B3498-7415-4DD5-9819-D2EBD606C2D9Q37260179-D707B462-77A1-4676-AC12-1F88B9C93445Q39131828-D64837D1-1471-4462-BE7F-0DE8B0F8615AQ39409549-576B16B7-D623-4CA0-A725-FBF501B597C9Q39996585-FBD50FF4-5E07-4228-8841-53E75C745C7DQ41039243-2193FB86-BD9A-487E-965D-F24FCAC1BAECQ41529622-6B5ADCD1-2D3F-4BB8-951C-C1DFDDF684FCQ43277441-F679BC57-1C17-4FB2-9F71-450A27A71718Q45075935-E35BFD74-D9FE-464D-A742-C74B02661F0CQ45124311-FC24BA2E-DADD-4CC9-864D-AF8B57D01390Q46794013-1C01A306-F5B9-4B21-BA16-F53AA6A965D4Q47104349-D6D9F18D-6315-4CDE-A550-94C302E19A49Q50649970-E92A25E2-1BEE-4DE7-AD35-19A453992324Q52599325-1DD5C95A-8DCF-4526-898C-4A4705A933B5Q53486967-259C90CE-1F03-4B5D-ABE4-97EC491BFA3AQ55654432-168478CF-3B66-4A6C-B788-4BA4220A0C53Q58008927-BFBE9B78-898D-4FFF-AEFE-8511E0FA24ABQ58008934-D9AF52BE-283C-4A5F-99B4-F34E84D29AF5Q91276423-4163C725-9669-4218-823C-B40EBD368A1BQ92136108-1253AD75-F939-4B5C-8312-A589F18FA4F0Q92392176-31DBF23A-F7D8-4884-9FCC-F23C15F10A9DQ96125729-620B2738-8269-4CAF-8225-B4D211DEABFB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gheun-Ho Kim
@ast
Gheun-Ho Kim
@en
Gheun-Ho Kim
@es
Gheun-Ho Kim
@nl
Gheun-Ho Kim
@sl
type
label
Gheun-Ho Kim
@ast
Gheun-Ho Kim
@en
Gheun-Ho Kim
@es
Gheun-Ho Kim
@nl
Gheun-Ho Kim
@sl
prefLabel
Gheun-Ho Kim
@ast
Gheun-Ho Kim
@en
Gheun-Ho Kim
@es
Gheun-Ho Kim
@nl
Gheun-Ho Kim
@sl
P106
P1153
7403061929
P31
P496
0000-0002-8445-9892